VivoSeq
Other

Decubitus Ulcer

2

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Decubitus Ulcer is an early-stage landscape with 2 programs across 0 companies. 1 therapy is approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

50/100

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 31

Collagenase Clostridium Histolyticum

Grupo Espanol de Tumores Neuroendocrinos

Approved1

Nitric Oxide

Mallinckrodt

Analysis

Trial Status

1

clinical trials

Recruiting1 · 100%

Clinical Trials

Trial Activity

Investigation of the Effect of Blood Pressure on Bedsores in Adult Internal Medicine Intensive Care Patients
Recruiting·YYuzuncu Yil University·N/A·NCT07696416·148 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)